Live Breaking News & Updates on Oesophageal

Stay updated with breaking news from Oesophageal. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

First French Recommendations on Eosinophilic Esophagitis

The main points of the forthcoming recommendations were described at the French-speaking Days of Hepato-Gastroenterology and Digestive Oncology. ....

Frank Zerbib , University Hospital Of Bordeaux , French National Society Of Gastroenterology , Department Of Hepato , French National Society , French Speaking Days , Digestive Oncology , University Hospital , Nt Specialty , Ead And Neck Surgery Ent Speciality , Eosinophilic Esophagitis Oesophagitis , Esophageal Achalasia , Chalasia Cardiae , Yssynergia Esophagus , Sophageal Aperistalsis Oesophageal Achalasia Dyssynergia Oesophagus , Swallowing Disorder ,

How Does Diet Affect Gastroesophageal Reflux Disease?

Meal intake reduced the tone of the lower esophageal sphincter and increased the number of transient lower esophageal sphincter relaxations. ....

United States , Frank Zerbib , Digestive Oncology At University Hospital Of Bordeaux , Francophone Days , Digestive Oncology , University Hospital , Gastroesophageal Reflux Disease Gerd Acid Gastro Oesophageal , Symptomatic Gastroesophageal Reflux Disease , Ymptomatic Gerd , Ymptomatic Acid Reflux Disease , Ymptomatic Gastro Oesophageal Reflux Disease , Lower Esophageal Sphincter , Ipid Management , Body Mass Index ,

First Patient Dosed With Drug Combo in Phase 2 Gastric Cancer Trial

A patient in a phase 2 trial has received the first dose of a novel combination of botensilimab and balstilimab plus agenT-979, an allogeneic cell therapy. ....

United States , Jennifer Buell , Yelena Janjigian , Gastrointestinal Oncology Service , American Cancer Society , Memorial Sloan Kettering Cancer Center , Mink Therapeutics , American Cancer , Chief Gastrointestinal Oncology Service , Vitrakvi Continues , Improve Survival , Slower Infusion , Antiemetic Drugs May Help With Nausea , Gastric Cancer , Agent 797 , Phase 2 Trial ,

Eosinophilic Esophagitis: 5 Things to Know

Although delayed diagnosis of EoE presents considerable risk to those with this chronic inflammatory disease, novel treatments are providing hope that a new era is on the horizon. ....

United States , New York , United Kingdom , Drug Administration , European Commission , Latin America , Middle East , Western Europe , New York City , Endoscopic Reference Score , Nt Specialty , Ead And Neck Surgery Ent Speciality , Food Allergy , Food Hypersensitivity , Esophageal Achalasia , Chalasia Cardiae , Yssynergia Esophagus , Sophageal Aperistalsis Oesophageal Achalasia Dyssynergia Oesophagus ,

FDA OKs First Oral Agent for Eosinophilic Esophagitis

Budesonide oral suspension is indicated for 12 weeks of treatment of EoE in adults and children as young as 11 years. ....

United States , Ikuo Hirano , Drug Administration , Esophageal Center , Northwestern University Feinberg School , Dysphagia Symptom Questionnaire , Nt Specialty , Ead And Neck Surgery Ent Speciality , Eosinophilic Esophagitis Oesophagitis , Erosive Esophagitis , Swallowing Disorder , Fungal Infection , Yeast Infection , Diarrhea Diarrhoea , Healthcare And Medical Technology ,